Month: April 2023

 Tryg’s Supervisory Board has today approved the interim report for Q1 2023*. Tryg is reporting for the first time under the new accounting standard, IFRS 17, in line with the insurance sector. Tryg has published comprehensive re-stated figures under IFRS 17 at the end of March, these are available on Tryg.com. The insurance service result target for 2024 under IFRS 17 has been increased from DKK 7.0-7.4bn to DKK 7.2-7.6bn driven primarily by a reclassification of insurance operating expenses. Tryg is also updating its expense ratio target to ~13.5% (~14.0%) while the combined ratio target at or below 82% is unchanged. Tryg reported a Q1 insurance service result of DKK 1,474m (DKK 1,014m), driven by a positive top-line development, across all business units, good development in the core business including the delivery of the RSA Scandinavia...

Strong start to the year with continued healthy growth in both sales and operating profit, and a robust improvement in cash flow First quarter of 2023Net sales increased by 19 percent to SEK 2,386 million (2,002). Organic growth was 0 percent and order intake was somewhat lower than net sales Operating profit (EBITA) increased by 33 percent to SEK 323 million (243) and the operating margin was 13.5 percent (12.1). Adjusted for items affecting comparability related to the closure of the Russian operations of SEK 0 million (-15), remeasured additional purchase considerations of SEK -2 million (-15) and acquisition costs of SEK 0 million (-8), operating profit increased by 16 percent to SEK 325 million (281), corresponding to an adjusted operating margin of 13.6 percent (14.0) Earnings per share increased by 21 percent to SEK 5.33 (4.42) Operating...

PRESS RELEASE: REGULATED INFORMATION20 April 2023, 07:00 CEST Biocartis Reports Results of First Quarter of 2023:16% Growth of Oncology Cartridge RevenuesGross Margin on Products of 37% and EBITDA of EUR -8.4m Mechelen, Belgium, 20 April 2023 – Biocartis Group NV (the “Company” or “Biocartis”), an innovative molecular diagnostics company (Euronext Brussels: BCART), today provides a business update for the first quarter of 2023 and the outlook for the full year 2023. Commenting on the Q1 2023 results, Herman Verrelst, Chief Executive Officer of Biocartis, said: “The start of 2023 was broadly in line with our expectations, with 16% growth of cartridge revenues in our core oncology business and a 35% gross margin. While we still expect to grow such product related revenues by 25-30% for the entire year, we saw Q1 2023...

By the end of the Q1 2023, Coop Pank had 155,000 customers, during the quarter the number of customers increased by 8,200 (+6%). The bank had 70,100 active customers, during the quarter the number of active customers increased by 3,300 (+5%). In Q1 2023, volume of deposits in Coop Pank increased by 5 million euros (+0.3%), reaching total of 1.51 billion euros. Deposits from private clients showed the fastest growth, increasing by 27 million euros: demand deposits decreased by 7 million euros and term deposits increased by 34 million euros. Deposits from domestic companies decreased by 23 million euros: demand deposits decreased by 94 million euros and term deposits increased by 71 million euros. Deposits from international deposit platform Raisin and other financing increased by 1 million euro. Compared to Q1 2022, volume of Coop Pank’s...

WithSecure Corporation, Interim report January-March 2023, 20 April 2023 at 8:00 EEST Interim Report 1 January – 31 March 2023 (“1st quarter” or “Q1 2023”) WithSecure Corporation interim report January-March 2023: Cloud revenue growth 31%, consulting impacted by uncertainty of the financial sector Highlights of January – March 2023Annual Recurring Revenue (ARR)1 for cloud products2 increased by 27% to EUR 81.5 million (EUR 64.1 million) ARR growth from previous quarter was 2 % Net Revenue Retention for cloud products was 110% Revenue from cloud products increased by 31% to EUR 19.9 million (EUR 15.2 million) Revenue from on-premise products decreased by 11% to EUR 6.4 million (EUR 7.1 million) Revenue from cyber security consulting decreased by 10% to EUR 8.9 million (EUR 10.0 million) Adjusted EBITDA was EUR -6.2 million (EUR -5.2 million...

Aspocomp Group Plc, Interim Report, April 20, 2023, at 8:00 a.m. EEST FIRST QUARTER 2023 HIGHLIGHTSNet sales EUR 8.9 (9.0) million, decrease of 1% Operating result EUR 0.3 (0.8) million, 3.8% (8.9%) of net sales Earnings per share EUR 0.04 (0.11) Operative cash flow EUR 1.6 (0.7) million Orders received EUR 13.7 (13.0) million, increase of 5% Order book at the end of the review period EUR 19.1 (20.5) million, decrease of 7% Equity ratio 72.9% (66.9%)OUTLOOK FOR 2023 Inflation and interest rates, the risk of recession and the uncertainties posed by Russia’s war of aggression will affect the operating environment of the company and its customers in the financial year 2023. The cycle of the Semiconductor Industry segment is expected to return to growth in the second half of the year. Aspocomp reiterates the guidance that was published...

Nokia CorporationInterim report20 April 2023 at 08:00 EEST Nokia Corporation Financial Report for Q1 2023 Strong net sales growth; outlook unchangedNet sales grew 9% y-o-y in constant currency (10% reported). Enterprise net sales grew 62% y-o-y in constant currency (65% reported). Comparable gross margin declined 300bps y-o-y to 37,7% (reported -310bps to 37,5%), due to regional mix and a lower contribution from Nokia Technologies partly related to a license option exercised in Q4 2022. Comparable operating margin declined y-o-y by 270bps to 8,2%, due to the above mentioned factors impacting gross margin along with a significant swing in venture fund contribution, somewhat offset by disciplined cost control. Reported operating margin increased 70bps y-o-y to 7,3%. In addition to the above factors, the margin increased due to a provision...